Loren C. Denlinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Loren C. Denlinger has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
Nizar N. Jarjour
Division of Allergy, Pulmonary and Critical Care Medicine
5 shared publicationsMario Castro
University of Kansas School of Medicine
4 shared publications- Nizar N. Jarjour
Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health , Madison, WI
4 shared publications - Stephane Esnault
Université de Lille, Inserm, Centre Hospitalier Universitaire (CHU) Lille, U1286, Institute for Translational Research in Inflammation , Lille F-59000
4 shared publications David M. Manthei
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
3 shared publications- Mats W. Johansson
Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health , 600 Highland Avenue, Madison, WI 53792
3 shared publications
Latest Publications
- 16 February 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 157 (6) , 1261-1273
PrecISE—a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort
- 16 February 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 157 (6) , 1261-1273
PrecISE—a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort
- 8 January 2026
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 118 (2)
Association between absolute blood eosinophil count and carotid plaque and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)
Prior studies have demonstrated associations between eosinophil activation products and incident stroke. We investigated whether circulating eosinophil concentration is associated with imaging markers of atherosclerotic cardiovascular disease (ASCVD), analyzing 2 arterial beds (carotid artery plaque [CAP] and coronary artery calcium [CAC]) in the Multi-Ethnic Study of Atherosclerosis (MESA). The MESA enrolled individuals aged 45 to 84, without ASCVD at baseline. ASCVD risk factors, blood eosinophils, CAP presence/score (0 to 12), and CAC presence/Agatston score were measured at MESA Exam No. 5. Using logistic and linear regression analyses, the relationships between blood eosinophils, CAP or CAC presence, or scores (log[score + 1]), adjusted for confounders, were evaluated. The 2,166 participants were a mean (standard deviation [SD]) 69.6 (9.3) years old, 53% female, 29% Hispanic, 28% Black, 1% Chinese American. The eosinophil count was median (interquartile range) 0.10 (0.10, 0.20)×103/μl, CAP score 2 (0, 4), and CAC score 45 (0, 292) Agatston units. In risk-factor adjusted models, increased blood eosinophil count (per 1 SD [0.15 × 103/μl]) was associated with log scores of CAP (β: 0.05 [95% confidence interval 0.02 to 0.08, P = 0.001) or CAC (β: 0.11, [0.01 to 0.21], P = 0.03). Similar associations were observed for eosinophils and CAP (odds ratio [OR]: 1.12, [1.01 to 1.25], P = 0.03) and CAC (OR: 1.15, [1.02 to 1.30], P = 0.02) presence. In conclusion, in a large, multiethnic US cohort, blood eosinophils were independently linked to imaging atherosclerosis measures in 2 arterial distributions. These data suggest potential roles of eosinophilic inflammation in atherosclerosis.
- 8 January 2026
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 118 (2)
Association between absolute blood eosinophil count and carotid plaque and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)
Prior studies have demonstrated associations between eosinophil activation products and incident stroke. We investigated whether circulating eosinophil concentration is associated with imaging markers of atherosclerotic cardiovascular disease (ASCVD), analyzing 2 arterial beds (carotid artery plaque [CAP] and coronary artery calcium [CAC]) in the Multi-Ethnic Study of Atherosclerosis (MESA). The MESA enrolled individuals aged 45 to 84, without ASCVD at baseline. ASCVD risk factors, blood eosinophils, CAP presence/score (0 to 12), and CAC presence/Agatston score were measured at MESA Exam No. 5. Using logistic and linear regression analyses, the relationships between blood eosinophils, CAP or CAC presence, or scores (log[score + 1]), adjusted for confounders, were evaluated. The 2,166 participants were a mean (standard deviation [SD]) 69.6 (9.3) years old, 53% female, 29% Hispanic, 28% Black, 1% Chinese American. The eosinophil count was median (interquartile range) 0.10 (0.10, 0.20)×103/μl, CAP score 2 (0, 4), and CAC score 45 (0, 292) Agatston units. In risk-factor adjusted models, increased blood eosinophil count (per 1 SD [0.15 × 103/μl]) was associated with log scores of CAP (β: 0.05 [95% confidence interval 0.02 to 0.08, P = 0.001) or CAC (β: 0.11, [0.01 to 0.21], P = 0.03). Similar associations were observed for eosinophils and CAP (odds ratio [OR]: 1.12, [1.01 to 1.25], P = 0.03) and CAC (OR: 1.15, [1.02 to 1.30], P = 0.02) presence. In conclusion, in a large, multiethnic US cohort, blood eosinophils were independently linked to imaging atherosclerosis measures in 2 arterial distributions. These data suggest potential roles of eosinophilic inflammation in atherosclerosis.
- 1 August 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (8) , 1515-1518
Proteomic Analysis of Asthma Airway Inflammation after Allergen Challenge: A Heterogeneous Response
- 1 August 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (8) , 1515-1518
Proteomic Analysis of Asthma Airway Inflammation after Allergen Challenge: A Heterogeneous Response
- Open Access
- 20 February 2025
- Published by Wiley in Physiological Reports
- Vol. 13 (4) , e70119
A method for MRI‐guided bronchoscopy to identify obstructed airway segments
Bronchoscopy is not conventionally guided by prior knowledge of segmental airway obstruction. Hyperpolarized gas magnetic resonance imaging (MRI) ventilation abnormalities and computed tomography (CT) air trapping are related to lung function and asthma severity but have not been used to target segmental inflammation and remodeling. We evaluate the feasibility of using bronchoscopy guided by 3He MRI and CT to reveal differences in inflammatory response, morphology, and cellular activity in poorly‐ (defect) versus well‐ventilated (control) lung regions. Eleven participants (5 female; age, 22.8 ± 3.4 years; 9 asthma) who experienced a cold with increased lower airway symptoms underwent 3He MRI and/or CT at least 6 weeks after recovery. Differences between defect and control regions were compared. In defect as compared to control sites, bronchoalveolar lavage neutrophils (p = 0.06) and granulocytes (p = 0.08) trended towards an increase; inflammatory mediators (i.e., 15‐epi‐LXA4, LXA4) were also significantly different (p < 0.05) between sites. Correlations were observed between macrophages, neutrophils, and eosinophils with inflammatory mediators (i.e., 15‐epi‐LXA4, LXA4, LTB4). Correlations were observed for macrophages and neutrophils with 15‐epi‐LXA4, and eosinophils with LXA4 and leukotriene B4. Basement membrane wall thickness was similar for defect versus control sites (p = 0.9). These results support the feasibility of image‐guided methods to identify airway obstruction phenotypes.
- 20 February 2025
- Published by Wiley in Physiological Reports
- Vol. 13 (4) , e70119
Open AccessA method for MRI‐guided bronchoscopy to identify obstructed airway segments
Bronchoscopy is not conventionally guided by prior knowledge of segmental airway obstruction. Hyperpolarized gas magnetic resonance imaging (MRI) ventilation abnormalities and computed tomography (CT) air trapping are related to lung function and asthma severity but have not been used to target segmental inflammation and remodeling. We evaluate the feasibility of using bronchoscopy guided by 3He MRI and CT to reveal differences in inflammatory response, morphology, and cellular activity in poorly‐ (defect) versus well‐ventilated (control) lung regions. Eleven participants (5 female; age, 22.8 ± 3.4 years; 9 asthma) who experienced a cold with increased lower airway symptoms underwent 3He MRI and/or CT at least 6 weeks after recovery. Differences between defect and control regions were compared. In defect as compared to control sites, bronchoalveolar lavage neutrophils (p = 0.06) and granulocytes (p = 0.08) trended towards an increase; inflammatory mediators (i.e., 15‐epi‐LXA4, LXA4) were also significantly different (p < 0.05) between sites. Correlations were observed between macrophages, neutrophils, and eosinophils with inflammatory mediators (i.e., 15‐epi‐LXA4, LXA4, LTB4). Correlations were observed for macrophages and neutrophils with 15‐epi‐LXA4, and eosinophils with LXA4 and leukotriene B4. Basement membrane wall thickness was similar for defect versus control sites (p = 0.9). These results support the feasibility of image‐guided methods to identify airway obstruction phenotypes.
- 17 June 2024
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 185 (11) , 1033-1047
Eosinophil-Epithelial Cell Interactions in Asthma
Background: Eosinophils have numerous roles in type 2 inflammation depending on their activation states in the blood and airway or after encounter with inflammatory mediators. Airway epithelial cells have a sentinel role in the lung and, by instructing eosinophils, likely have a foundational role in asthma pathogenesis. Summary: In this review, we discuss various topics related to eosinophil-epithelial cell interactions in asthma, including the influence of eosinophils and eosinophil products, e.g., granule proteins, on epithelial cell function, expression, secretion, and plasticity; the effects of epithelial released factors, including oxylipins, cytokines, and other mediators on eosinophils, e.g., on their activation, expression, and survival; possible mechanisms of eosinophil-epithelial cell adhesion; and the role of intra-epithelial eosinophils in asthma. Key Messages: We suggest that eosinophils and their products can have both injurious and beneficial effects on airway epithelial cells in asthma and that there are bidirectional interactions and signaling between eosinophils and airway epithelial cells in asthma.
- 17 June 2024
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 185 (11) , 1033-1047
Eosinophil-Epithelial Cell Interactions in Asthma
Background: Eosinophils have numerous roles in type 2 inflammation depending on their activation states in the blood and airway or after encounter with inflammatory mediators. Airway epithelial cells have a sentinel role in the lung and, by instructing eosinophils, likely have a foundational role in asthma pathogenesis. Summary: In this review, we discuss various topics related to eosinophil-epithelial cell interactions in asthma, including the influence of eosinophils and eosinophil products, e.g., granule proteins, on epithelial cell function, expression, secretion, and plasticity; the effects of epithelial released factors, including oxylipins, cytokines, and other mediators on eosinophils, e.g., on their activation, expression, and survival; possible mechanisms of eosinophil-epithelial cell adhesion; and the role of intra-epithelial eosinophils in asthma. Key Messages: We suggest that eosinophils and their products can have both injurious and beneficial effects on airway epithelial cells in asthma and that there are bidirectional interactions and signaling between eosinophils and airway epithelial cells in asthma.
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (4) , 338-352
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents
Park SY, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):338-352. https://doi.org/10.4168/aair.2024.16.4.338
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (4) , 338-352
Open AccessComparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents
Park SY, et al. Allergy Asthma Immunol Res. 2024 Jul;16(4):338-352. https://doi.org/10.4168/aair.2024.16.4.338
- 19 July 2023
- Published by Springer Nature
- Vol. 1426, 163-184
Imaging Regional Airway Involvement of Asthma: Heterogeneity in Ventilation, Mucus Plugs and Remodeling
The imaging of asthma using chest computed tomography (CT) is well-established (Jarjour et al., Am J Respir Crit Care Med 185(4):356–62, 2012; Castro et al., J Allergy Clin Immunol 128:467–78, 2011). Moreover, recent advances in functional imaging of the lungs with advanced computer analysis of both CT and magnetic resonance images (MRI) of the lungs have begun to play a role in quantifying regional obstruction. Specifically, quantitative measurements of the airways for bronchial wall thickening, luminal narrowing and distortion, the amount of mucus plugging, parenchymal density, and ventilation defects that could contribute to the patient’s disease course are instructive for the entire care team. In this chapter, we will review common imaging methods and findings that relate to the heterogeneity of asthma. This information can help to guide treatment decisions. We will discuss mucous plugging, quantitative assessment of bronchial wall thickening, delta lumen phenomenon, parenchymal low-density lung on CT, and ventilation defect percentage on MRI as metrics for assessing regional ventilatory dysfunction. Keywords Computed tomography Small airways disease Hyper Polarized Disease probability measure Airway network flow model Magnetic resonance imaging Regional airflow Mucus plugs Remodeling
- 19 July 2023
- Published by Springer Nature
- Vol. 1426, 163-184
Imaging Regional Airway Involvement of Asthma: Heterogeneity in Ventilation, Mucus Plugs and Remodeling
The imaging of asthma using chest computed tomography (CT) is well-established (Jarjour et al., Am J Respir Crit Care Med 185(4):356–62, 2012; Castro et al., J Allergy Clin Immunol 128:467–78, 2011). Moreover, recent advances in functional imaging of the lungs with advanced computer analysis of both CT and magnetic resonance images (MRI) of the lungs have begun to play a role in quantifying regional obstruction. Specifically, quantitative measurements of the airways for bronchial wall thickening, luminal narrowing and distortion, the amount of mucus plugging, parenchymal density, and ventilation defects that could contribute to the patient’s disease course are instructive for the entire care team. In this chapter, we will review common imaging methods and findings that relate to the heterogeneity of asthma. This information can help to guide treatment decisions. We will discuss mucous plugging, quantitative assessment of bronchial wall thickening, delta lumen phenomenon, parenchymal low-density lung on CT, and ventilation defect percentage on MRI as metrics for assessing regional ventilatory dysfunction. Keywords Computed tomography Small airways disease Hyper Polarized Disease probability measure Airway network flow model Magnetic resonance imaging Regional airflow Mucus plugs Remodeling
- 19 July 2023
- Published by Springer Nature
- Vol. 1426, 395-412
Clinical Trial Design Innovations for Precision Medicine in Asthma
Severe asthma is a spectrum disorder with numerous subsets, many of which are defined by clinical history and a general predisposition for T2 inflammation. Most of the approved therapies for severe asthma have required clinical trial designs with population enrichment for exacerbation frequency and/or elevation of blood eosinophils. Moving beyond this framework will require trial designs that increase efficiency for studying nondominant subsets and continue to improve upon biomarker signatures. In addition to reviewing the current literature on biomarker-informed trials for severe asthma, this chapter will also review the advantages of master protocols and adaptive design methods for establishing the efficacy of new interventions in prospectively defined subsets of patients. The incorporation of methods that allow for data collection outside of traditional study visits at academic centers, called remote decentralized trial design, is a growing trend that may increase diversity in study participation and allow for enhanced resiliency during the COVID-19 pandemic. Finally, reaching the goals of precision medicine in asthma will require increased emphasis on effectiveness studies. Recent advances in real-world data utilization from electronic health records are also discussed with a view toward pragmatic trial designs that could also incorporate the evaluation of biomarker signatures. Keywords Phenotypes Endotypes Longitudinal analysis Cohort Lung function Biomarkers Risk estimate Placebo-controlled trials Exacerbation Intervention Stratification
- 19 July 2023
- Published by Springer Nature
- Vol. 1426, 395-412
Clinical Trial Design Innovations for Precision Medicine in Asthma
Severe asthma is a spectrum disorder with numerous subsets, many of which are defined by clinical history and a general predisposition for T2 inflammation. Most of the approved therapies for severe asthma have required clinical trial designs with population enrichment for exacerbation frequency and/or elevation of blood eosinophils. Moving beyond this framework will require trial designs that increase efficiency for studying nondominant subsets and continue to improve upon biomarker signatures. In addition to reviewing the current literature on biomarker-informed trials for severe asthma, this chapter will also review the advantages of master protocols and adaptive design methods for establishing the efficacy of new interventions in prospectively defined subsets of patients. The incorporation of methods that allow for data collection outside of traditional study visits at academic centers, called remote decentralized trial design, is a growing trend that may increase diversity in study participation and allow for enhanced resiliency during the COVID-19 pandemic. Finally, reaching the goals of precision medicine in asthma will require increased emphasis on effectiveness studies. Recent advances in real-world data utilization from electronic health records are also discussed with a view toward pragmatic trial designs that could also incorporate the evaluation of biomarker signatures. Keywords Phenotypes Endotypes Longitudinal analysis Cohort Lung function Biomarkers Risk estimate Placebo-controlled trials Exacerbation Intervention Stratification
- 14 July 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (11) , 3425-3434.e4
Development and Dynamic Responsiveness of the Acute Asthma Exacerbation Survey in Patients With Moderate to Severe Disease
- 14 July 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (11) , 3425-3434.e4
Development and Dynamic Responsiveness of the Acute Asthma Exacerbation Survey in Patients With Moderate to Severe Disease